Sabatier, R.; Charafe-Jauffret, E.; Pierga, J.-Y.; Curé, H.; Lambaudie, E.; Genre, D.; Houvenaeghel, G.; Viens, P.; Ginestier, C.; Bertucci, F.;
et al. Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer. J. Clin. Med. 2019, 8, 612.
https://doi.org/10.3390/jcm8050612
AMA Style
Sabatier R, Charafe-Jauffret E, Pierga J-Y, Curé H, Lambaudie E, Genre D, Houvenaeghel G, Viens P, Ginestier C, Bertucci F,
et al. Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer. Journal of Clinical Medicine. 2019; 8(5):612.
https://doi.org/10.3390/jcm8050612
Chicago/Turabian Style
Sabatier, Renaud, Emmanuelle Charafe-Jauffret, Jean-Yves Pierga, Hervé Curé, Eric Lambaudie, Dominique Genre, Gilles Houvenaeghel, Patrice Viens, Christophe Ginestier, François Bertucci,
and et al. 2019. "Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer" Journal of Clinical Medicine 8, no. 5: 612.
https://doi.org/10.3390/jcm8050612
APA Style
Sabatier, R., Charafe-Jauffret, E., Pierga, J.-Y., Curé, H., Lambaudie, E., Genre, D., Houvenaeghel, G., Viens, P., Ginestier, C., Bertucci, F., Sfumato, P., Extra, J.-M., & Gonçalves, A.
(2019). Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer. Journal of Clinical Medicine, 8(5), 612.
https://doi.org/10.3390/jcm8050612